HTD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Corcept Therapeutics Inc

Watchlist Manager

Watchlist

Price: 101.45 EUR 3.23% Market Closed

Market Cap: €10.5B

C	Corcept Therapeutics Inc XMUN:HTD	US
C	Corcept Therapeutics Inc F:HTD	US
S	Swiss Re AG XMUN:SR9	CH
	ING Groep NV F:INN1	NL
C	CME Group Inc DUS:MX4A	US
J	JCDecaux SE XMUN:DCS	FR

Profitability Summary

Corcept Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

99% > 98%

Low Operating Margin

Sustainable 3Y Average Operating Margin

15%

Declining Operating Margin

23% > 1%

Low Net Margin

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

22% > 7%

Exceptional Free Cash Flow Margin

13%

Strong 3Y Average Free Cash Flow Margin

23%

Declining Free Cash Flow Margin

31% > 13%

Low ROE

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

31%

Declining ROIC

63% > 3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.